Prevention of Cisplatin Neurotoxicity with an ACTH(4–9) Analogue in Patients with Ovarian Cancer
van der Hoop, Roland Gerritsen, Vecht, Charles J, van der Burg, Maria E.L, Elderson, Arthur, Boogerd, Willem, Heimans, Jan J, Vries, Els P, van Houwelingen, Johannes C, Jennekens, Frans G.I, Gispen, Willem H, Neijt, Jean P
Published in The New England journal of medicine (11.01.1990)
Published in The New England journal of medicine (11.01.1990)
Get full text
Journal Article
A phase II study of epidoxorubicin in colorectal cancer and the use of cyclosporin-A in an attempt to reverse multidrug resistance
Verweij, J, Herweijer, H, Oosterom, R, van der Burg, M E, Planting, A S, Seynaeve, C, Stoter, G, Nooter, K
Published in British journal of cancer (01.08.1991)
Published in British journal of cancer (01.08.1991)
Get full text
Journal Article
Molecular profiling of platinum resistant ovarian cancer
Helleman, Jozien, Jansen, Maurice P.H.M., Span, Paul N., van Staveren, Iris L., Massuger, Leon F.A.G., Meijer‐van Gelder, Marion E., Sweep, Fred C.G.J., Ewing, Patricia C., van der Burg, Maria E.L., Stoter, Gerrit, Nooter, Kees, Berns, Els M.J.J.
Published in International journal of cancer (15.04.2006)
Published in International journal of cancer (15.04.2006)
Get full text
Journal Article
Weekly high-dose cisplatin is a feasible treatment option: analysis on prognostic factors for toxicity in 400 patients
DE JONGH, F. E, VAN VEEN, R. N, VELTMAN, S. J, DE WIT, R, VAN DER BURG, M. E. L, VAN DEN BENT, M. J, PLANTING, Asth, GRAVELAND, W. J, STOTER, G, VERWEIJ, J
Published in British journal of cancer (22.04.2003)
Published in British journal of cancer (22.04.2003)
Get full text
Journal Article
The prediction of progression‐free and overall survival in women with an advanced stage of epithelial ovarian carcinoma
Gerestein, CG, Eijkemans, MJC, de Jong, D, van der Burg, MEL, Dykgraaf, RHM, Kooi, GS, Baalbergen, A, Burger, CW, Ansink, AC
Published in BJOG : an international journal of obstetrics and gynaecology (01.02.2009)
Published in BJOG : an international journal of obstetrics and gynaecology (01.02.2009)
Get full text
Journal Article
Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group
Aapro, M. S., van Wijk, F. H., Bolis, G., Chevallier, B., van der Burg, M. E. L., Poveda, A., de Oliveira, C. F., Tumolo, S., Scotto di Palumbo, V., Piccart, M., Franchi, M., Zanaboni, F., Lacave, A. J., Fontanelli, R., Favalli, G., Zola, P., Guastalla, J. P., Rosso, R., Marth, C., Nooij, M., Presti, M., Scarabelli, C., Splinter, T. A. W., Ploch, E., Beex, L. V. A., ten Bokkel Huinink, W., Forni, M., Melpignano, M., Blake, P., Kerbrat, P., Mendiola, C., Cervantes, A., Goupil, A., Harper, P. G., Madronal, C., Namer, M., Scarfone, G., Stoot, J. E. G. M., Teodorovic, I., Coens, C., Vergote, I., Vermorken, J. B.
Published in Annals of oncology (01.03.2003)
Published in Annals of oncology (01.03.2003)
Get full text
Journal Article
Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapy
POLES, M. B, HOP, W. C. J, KOK, T. C, ESKENS, Falm, VAN DER BURG, M. E. L, SPLINTER, T. A. W, SIERSEMA, P. D, TILANUS, H. W, STOTER, G, VAN DER GAAST, A
Published in British journal of cancer (01.12.2003)
Published in British journal of cancer (01.12.2003)
Get full text
Journal Article
Conference Proceeding
A phase I and pharmacologic study of the MDR converter GF120918 in combination with doxorubicin in patients with advanced solid tumors
PLANTING, A. S. T, SONNEVELD, P, PAUL, E. M, PURVIS, N. B, VERWEIJ, J, VAN DER GAAST, A, SPARREBOOM, A, VAN DER BURG, M. E. L, LUYTEN, G. P. M, DE LEEUW, K, DE BOER-DENNERT, M, WISSEL, P. S, JEWELL, R. C
Published in Cancer chemotherapy and pharmacology (2005)
Published in Cancer chemotherapy and pharmacology (2005)
Get full text
Journal Article
Phase II study of bi-weekly administration of paclitaxel and cisplatin in patients with advanced oesophageal cancer
POLEE, M. B, ESKENS, Falm, VAN DER BURG, M. E. L, SPLINTER, T. A. W, SIERSEMA, P. D, TILANUS, H. W, VERWEIJ, J, STOTER, G, VAN DER GAAST, A
Published in British journal of cancer (04.03.2002)
Published in British journal of cancer (04.03.2002)
Get full text
Journal Article
Reduced expression of BAX is associated with poor prognosis in patients with epithelial ovarian cancer: a multifactorial analysis of TP53, p21, BAX and BCL-2
SCHUYER, M, VAN DER BURG, M. E. L, HENZEN-LOGMANS, S. C, FLERET, J. H, KLIJN, J. G. M, LOOK, M. P, FOEKENS, J. A, STOTER, G, BERNS, Emjj
Published in British journal of cancer (02.11.2001)
Published in British journal of cancer (02.11.2001)
Get full text
Journal Article
The Orally Administered P-glycoprotein Inhibitor R101933 Does Not Alter the Plasma Pharmacokinetics of Docetaxel
VAN ZUYLEN, L, SPARREBOOM, A, VAN DER GAAST, A, VAN DER BURG, M. E. L, VAN BEURDEN, V, BOL, C. J, WOESTENBORGHS, R, PALMER, P. A, VERWEIJ, J
Published in Clinical cancer research (01.04.2000)
Get full text
Published in Clinical cancer research (01.04.2000)
Journal Article
Alterations in the p53 pathway and prognosis in advanced ovarian cancer: A multi-factorial analysis of the EORTC Gynaecological Cancer group (study 55865)
Green, J.A., Berns, E.M.J.J., Coens, C., van Luijk, I., Thompson-Hehir, J., van Diest, P., Verheijen, R.H.M., van de Vijver, M., van Dam, P., Kenter, G.G., Tjalma, W., Ewing, P.C., Teodorovic, I., Vergote, I., van der Burg, M.E.L.
Published in European journal of cancer (1990) (01.10.2006)
Published in European journal of cancer (1990) (01.10.2006)
Get full text
Journal Article
What is the role of dose‐dense therapy?
BURG, M.E.L., Van Der GAAST, A., VERGOTE, I., BURGER, C.W., Van DOORN, H.C., De WIT, R., STOTER, G., VERWEIJ, J.
Published in International journal of gynecological cancer (01.11.2005)
Published in International journal of gynecological cancer (01.11.2005)
Get full text
Journal Article
Phase II study of bleomycin, vindesine, mitomycin C and cisplatin (BEMP) in recurrent or disseminated squamous cell carcinoma of the uterine cervix
van Luijk, I.F., Coens, C., van der Burg, M.E.L., Kobierska, A., Namer, M., Lhomme, C., Zola, P., Zanetta, G., Vermorken, J.B.
Published in Annals of oncology (01.02.2007)
Published in Annals of oncology (01.02.2007)
Get full text
Journal Article
Relationship between the exposure to cisplatin, DNA-adduct formation in leucocytes and tumour response in patients with solid tumours
SCHELLENS, J. H. M, MA, J, PLANTING, A. S. T, VAN DER BURG, M. E. L, VAN MEERTEN, E, DE BOER-DENNERT, M, SCHMITZ, P. I. M, STOTER, G, VERWEIJ, J
Published in British journal of cancer (01.06.1996)
Published in British journal of cancer (01.06.1996)
Get full text
Journal Article
Disposition of Cremophor EL in humans limits the potential for modulation of the multidrug resistance phenotype in vivo
SPARREBOOM, A, VERWEIJ, J, GIANNI, L, VAN DER BURG, M. E. L, LOOS, W. J, BROUWER, E, VIGANO, L, LOCATELLI, A, DE VOS, A. I, NOOTER, K, STOTER, G
Published in Clinical cancer research (01.08.1998)
Get full text
Published in Clinical cancer research (01.08.1998)
Journal Article
Dose-dense cisplatin/paclitaxel: a well-tolerated and highly effective chemotherapeutic regimen in patients with advanced ovarian cancer
de Jongh, F.E, de Wit, R, Verweij, J, Sparreboom, A, van den Bent, M.J, Stoter, G, van der Burg, M.E.L
Published in European journal of cancer (1990) (01.10.2002)
Published in European journal of cancer (1990) (01.10.2002)
Get full text
Journal Article